SLIDE 4 4 | [footer text here]
Interventions prior to pharmacotherapy
§ Active lifestyle – walk to and from the bus taking him to work § Meal delivery system that emphasizes plant-based foods § Stop refined carbohydrates and added sugars at work § No eating after dinner § Set 5% weight loss goal § Reassess in 3 months § Repeat
13
13
Propensity towards harm through
- verdiagnosis and overtreatment
§ Designation of a pre-existing condition § Multiple medications cause significant side effects § 80% of people with newly diagnosed hypertension according to the ACC/AHA
guideline would have no expected benefit in terms of CVD risk reduction with BP lowering (<130/80)
§ SPRINT: 63 people needed to be treated for 3.3 years to prevent 1 from
experiencing a CVD event
§ SPRINT: 50 people treated intensively over 3.3 years, 1 person experienced a
serious adverse drug effect
Katy J. L. Bell, Jenny Doust, Paul Glasziou. Incremental Benefits and Harms of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. JAMA Internal Medicine, 2018.
14
15
Case 3
75 year old South Asian male with HTN, well-controlled hyperlipidemia and gout. He maintains a lacto-ovo vegetarian diet and briskly walks 3 miles daily. His medications include benazepril 10mg daily, allopurinol 100mg daily and crestor 5mg daily. He is afebrile, HR 64, BP 138/74. Physical exam is unremarkable. What would be your threshold for treatment escalation?
15
16
Adults over Age 60: No improvement and some harm
§ Increased risk of syncope (RR 1.52 [CI1.22-2.07]) § No improvement in renal outcomes, cognitive decline or dementia targeting lower
- vs. higher blood pressure goal
§ No change in risk of fractures or falls, quality of life or functional status between
140/90 vs 130/80
§ Subgroup analysis of SPRINT showed trend towards increase hypotension,
syncope, electrolyte abnormalities, AKI in patients 75 and older
§ Secondary prevention of stroke: RR, 0.76 [CI, 0.66 to 0.92] with BP<140/90
- Supported by the National Kidney Foundation
Quaseem et al. Ann Intern Med. 2017;166(6):430-437
16